APA (7th ed.) Citation

EM, G., D, W., D, I., C, G., L, L., MA, D., & Group, A. (2010). Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis & Rheumatism, 62(1), 211. https://doi.org/10.1002/art.25052

Chicago Style (17th ed.) Citation

EM, Ginzler, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA, and ALMS Group. "Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis: Findings in a Multicenter, Prospective, Randomized, Open-label, Parallel-group Clinical Trial." Arthritis & Rheumatism 62, no. 1 (2010): 211. https://doi.org/10.1002/art.25052.

MLA (9th ed.) Citation

EM, Ginzler, et al. "Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis: Findings in a Multicenter, Prospective, Randomized, Open-label, Parallel-group Clinical Trial." Arthritis & Rheumatism, vol. 62, no. 1, 2010, p. 211, https://doi.org/10.1002/art.25052.